MDA -Medical Development Agency
Clinical Research Organization – medicine registration, clinical trials, market access in Russia
- +7 (495) 74-88-777
- info@mda-cro.com
- 121096, G. Moscow Krasnopresnenskaya NAB., D. 12, subzero 3, office 1104a
- Mon - Fri: 9:00 - 18:00
MDA-CRO in Russia
Our main areas of activities - regulatory affairs procedures in Russia consultancy, organizing and conducting pre-clinical and clinical trials, post approval research, post marketing studies, phase IV trials and patient registries, bioequivalence trials, consulting services on pharmacovigilance, medicine registration for pharmaceuticals in Russia, and a variety of medical and social projects.
Our team
Medical Development Agency employees are not just experienced professionals with a solid background of knowledge, skills and successfully implemented projects. We are a friendly, close-knit team that ensures a high level of efficiency of our work and the company's competitiveness in the market.
Our achievements
0
Successful project
0
Registrations
0
Market analysis
0
Clients
About our company
Medical Development Agency (MDA)
Contract Research Organization (CRO) Medical Development Agency has been operating in Russia since 2011. Our main areas of activities - regulatory affairs procedures in Russia consultancy, organizing and conducting pre-clinical and clinical trials, post approval research, post marketing studies, phase IV trials and patient registries, bioequivalence trials, consulting services on pharmacovigilance, medicine registration, market access for pharmaceuticals in Russia, and a variety of medical and social projects.
Our staff consists of managers with solid knowledge and skills who have successfully completed a vast number of projects. It is also a friendly, close-knit team, contributing high level of efficiency and competitiveness in the market to our company.
High quality services provided by us have been highly appreciated by our clients with leading international and Russian pharmaceutical companies among.
Medical Development Agency's reputation as a reliable partner is based on strong principles and rules that we strictly follow.
Why choose us?
Medical Development Agency's reputation as a reliable partner is based on strong principles and rules that we strictly follow.
Professional
team
High level
of efficiency
100% process
control
Awards &
Diplomas
Conferences &
Congresses
Quality &
Accreditation
Our services
List of essential services provided by Medical Development Agency (MDA)
Regulatory Affairs
Clinical trials in Russia
Bioequivalence
GMP inspection
Market access
Pharmacovigilance
Pharmacoeconomics
Pharmaceutical Regulatory Affairs in Russia
We provide a full range of services for the state registration of medicines in Russia EEU / CIS.
Read more
Clinical trials in Russia.
Clinical research in Russia is not only a necessary component in any development of new drugs. Clinical trial results, efficacy and safety data should be submitted to regulatory authorities.
Read more
Bioequivalence studies in Russia
Bioequivalence means that the reconstituted drug active ingredient is absorbed by the body with the same speed and in the same amount as the original product.
Read more
GMP inspection
Starting from 2016, all pharmaceutical companies must submit a copy of their compliance report when registering new medicines (LP) ...
Read more
Market access
Specialists and consultants of Medical Development Agency understand the changing national health system environment and can correctly evaluate its impact on your business...
Read more
Pharmacovigilance
Our Medical Writing Solutions are designed to provide our clients with unmatched expertise, collaborative efficiency, unprecedented quality registration documents and primary manuscripts.
Read more
Pharmacoeconomics
Medical Development Agency has a broad and deep experience in the field of post-approval studies in Russia, combined with a solid base in the late-stage clinical trials management.
Read more
News
News of drug registration and clinical trials
News of the EAEU
The Board of the Eurasian economic Commission approved The "guidelines for preclinical safety
And again about the labeling of drugs
The state Duma Committee on health protection approved the draft Federal law "on amendments to
Pharmacovigilance
On 15 October, the Committee of the European Directorate for quality of medical products (EDQM)
Economic indicators of the Russian pharmaceutical market in October
According to the analytical Agency DSM Group, the volume of the Russian commercial LP market in